Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions.

Autor: Thomas W Georgi, Lars Kurch, Dirk Hasenclever, Victoria S Warbey, Lucy Pike, John Radford, Osama Sabri, Regine Kluge, Sally F Barrington

Publikováno v: PLoS ONE, Vol 18, Iss 3, p e0283694 (2023)

IntroductionInterim PET (iPET) assessment is important for response adaptation in Hodgkin lymphoma (HL). The current standard for iPET assessment is the Deauville score (DS). The aim of our study was to evaluate the causes of interobserver variabilit

Externí odkaz: https://doaj.org/article/2d1e470bcb8c47d7af37e13d1c56ee9c

Proceedings of the International Cancer Imaging Society (ICIS) 16th Annual Teaching Course

Autor: Dow-Mu Koh, Sue Creviston Kaste, Sarah J. Vinnicombe, Giovanni Morana, Andrea Rossi, Christian J. Herold, Theresa C. McLoud, Kirk A. Frey, Bernhard Gebauer, Derek Roebuck, Jurgen J. Fütterer, Alexander J. Towbin, Thierry A. G. Huisman, Anne M. J. B. Smets, Jeong Min Lee, Hersh Chandarana, Marius E. Mayerhoefer, Markus Raderer, Alexander Haug, Matthias Eiber, Andrea Rockall, Aslam Sohaib, Victoria S Warbey, Hebert Alberto Vargas, Jay P. Heiken, Isaac R. Francis, Mahmoud M. Al-Hawary, Ravi K. Kaza, Mirko D’Onofrio, Harriet C. Thoeny, Ann D. King, Arnoldo Piccardo, Maria Luisa Garrè, Nick Reed, Carlos Rodriguez-Galindo, Ashish P. Wasnik, Stefan Diederich, Wim J. G. Oyen, Cheng Lee Chaw, Nicholas van As, Igor Vieira, Frederik De Keyzer, Elleke Dresen, Sileny Han, Ignace Vergote, Philippe Moerman, Frederic Amant, Michel Koole, Vincent Vandecaveye, R. Dresen, S. De Vuysere, F. De Keyzer, E. Van Cutsem, A. D’Hoore, A. Wolthuis, V. Vandecaveye, P. Pricolo, S. Alessi, P. Summers, E. Tagliabue, G. Petralia, C. Pfannenberg, B. Gückel, S. C. Schüle, A. C. Müller, S. Kaufmann, N. Schwenzer, M. Reimold, C. la Fougere, K. Nikolaou, P. Martus, G. J. Cook, G. K. Azad, B. P. Taylor, M. Siddique, J. John, J. Mansi, M. Harries, V. Goh, S. Seth, R. Burgul, A. Seth, S. Waugh, N. Muhammad Gowdh, C. Purdie, A. Evans, E. Crowe, A. Thompson, S. Vinnicombe, F. Arfeen, T. Campion, E. Goldstraw, M. D’Onofrio, V. Ciaravino, S. Crosara, R. De Robertis, R. Pozzi Mucelli, M. Uhrig, D. Simons, H. Schlemmer, Kate Downey, S. Murdoch, A. S. Al-adhami, S. Viswanathan, S. Smith, P. Jennings, D. Bowers, R. Soomal, T. M. Mutala, A. O. Odhiambo, N. Harish, M. Hall, M. Sproule, S. Sheridan, K. Y. Thein, C. H. Tan, Y. L. Thian, C. M. Ho, S. De Luca, C. Carrera, V. Blanchet, L. Alarcón, E. Eyheremnedy, B. K. Choudhury, K. Bujarbarua, G. Barman, E. Lovat, R. Ferner, V. S. Warbey, L. Potti, B. Kaye, A. Beattie, K. Dutton, A. A. Seth, F. Constantinidis, H. Dobson, R. Bradley, G. Bozas, G. Avery, A. Stephens, A. Maraveyas, S. Bhuva, C. A. Johnson, M. Subesinghe, N. Taylor, L. E. Quint, R. M. Reddy, G. P. Kalemkerian, G. González Zapico, E. Gainza Jauregui, R. Álvarez Francisco, S. Ibáñez Alonso, I. Tavera Bahillo, L. Múgica Álvarez, O. Francies, R. Wheeler, L. Childs, A. Adams, A. Sahdev, S. E. De Luca, M. E. Casalini Vañek, M. D. Pascuzzi, T. Gillanders, P. M. Ramos, E. P. Eyheremendy, C. Stove, M. Digby, M. Nazar, M. Wirtz, F. Troncoso, F. Saguier, D. J. Quint, L. Dang, M. Carlson, S. Leber, F. Silverstein, R. Rueben, B. Nazir, T. H. Teo, J. B. Khoo, K. Sharma, N. Gupta, B. Mathew, T. Jeyakumar, K. Harkins, S. Joshua, D. Christodoulou, S. Gourtsoyianni, A. Jacques, N. Griffin, J. Lee, J. A. Goodfellow, A. Yong, S. Jenkins, G. Joseph, K. Partington, A. Zanfardini, K. Cavanagh, E. Lau

Publikováno v: Cancer Imaging, Vol 16, Iss S1, Pp 1-34 (2016)

Table of contents O1 Tumour heterogeneity: what does it mean? Dow-Mu Koh O2 Skeletal sequelae in adult survivors of childhood cancer Sue Creviston Kaste O3 Locoregional effects of breast cancer treatment Sarah J Vinnicombe O4 Imaging of cancer therap

Externí odkaz: https://doaj.org/article/bbc9ed6b29934836b9bbcd92740a4db6

A Phase II, Open-label study to assess safety and management change using

Autor: Asim, Afaq, Heather, Payne, Reena, Davda, John, Hines, Gary J R, Cook, Marie, Meagher, Dimitrios, Priftakis, Victoria S, Warbey, Anand, Kelkar, Clement, Orczyk, Anita, Mitra, Sarah, Needleman, Michael, Ferris, Greg, Mullen, Jamshed, Bomanji

Publikováno v: J Nucl Med

Our objectives were to assess the safety and clinical impact of a novel, kit-based formulation of (68)Ga-tris(hydroxypyridinone) ((68)Ga-THP) prostate-specific membrane antigen (PSMA) for PET/CT in guiding the management of patients with prostate can

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3d654a83f2398e791a13b5e20a08fff7
https://pubmed.ncbi.nlm.nih.gov/33741648

The management impact of

Autor: Meghana, Kulkarni, Simon, Hughes, Andrew, Mallia, Victoria, Gibson, Jennifer, Young, Ajay, Aggarwal, Stephen, Morris, Ben, Challacombe, Rick, Popert, Christian, Brown, Paul, Cathcart, Prokar, Dasgupta, Victoria S, Warbey, Gary J R, Cook

Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging

Purpose To determine the impact on clinical management of patients with high-risk (HR) prostate cancer at diagnosis and patients with biochemical recurrence (BCR) using a new kit form of 68Ga-prostate-specific membrane antigen (PSMA), namely tris(hyd

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2eb4b609bd513df12edb9ea6a9b148fc
https://pubmed.ncbi.nlm.nih.gov/31872280